Trial Details
TERMINATEDBasic Information
| Clinical ID | c3062 |
|---|---|
| Identifier | NCT02574637 |
| Trial Title | Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Brazikumab IV Infusion|DRUG: Brazikumab SC Injection|DRUG: Placebo |
Participant Information
| Sponsor | AstraZeneca |
|---|---|
| City | Phoenix |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2016-01-05 |
|---|---|
| Primary Completion Date | 2017-07-28 |
| Completion Date | 2018-01-29 |